James A. Bristol

Dr. James A. Bristol is a Senior Advisor with Frazier Healthcare and also serves as chairman of Deciphera Pharmaceuticals (NASDAQ: DCPH) and a member of Board of Directors of Erasca, Inc. (NASDAQ: ERAS). Dr. Bristol worked for 32 years in drug discovery, research and preclinical development at Schering-Plough Corporation, Parke-Davis, and Pfizer Inc., serving in various senior research and development roles. From 2003 until his retirement in 2007, Dr. Bristol served as Senior Vice President of Worldwide Drug Discovery Research at Pfizer Global Research and Development, where he oversaw 3,000 scientists at seven Pfizer sites as they produced an industry-leading number of drug development candidates in 11 therapeutic areas. Dr. Bristol is the author of over 100 publications, abstracts and patents. He conducted postdoctoral research at the University of Michigan (NIH Postdoctoral Fellow) and at The Squibb Institute for Medical Research. Dr. Bristol received a B.S. in Chemistry from Bates College and a Ph.D. in organic chemistry from the University of New Hampshire.